ENvue Medical, Inc. Deferred Federal Income Tax Expense (Benefit)
ENvue Medical, Inc. (FEED) reported Deferred Federal Income Tax Expense (Benefit) of -$331.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-04-15
- ENvue Medical, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was -$331.00K.
- ENvue Medical, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was -$815.48K.
- ENvue Medical, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was -$1.23M.
- ENvue Medical, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$1.54B.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$331.00K 10-K · filed 2026-04-15 | |
| 2024-12-31 | -$815.48K 10-K · filed 2025-03-31 | |
| 2023-12-31 | -$1.23M 10-K · filed 2025-03-31 | -$1.23B 10-K · filed 2024-04-08 |
| 2022-12-31 | -$1.54B 10-K · filed 2024-04-08 | -$1.54M 10-K · filed 2023-04-17 |
| 2021-12-31 | -$1.26M 10-K · filed 2023-04-17 | |
| 2020-12-31 | -$584.00K 10-K · filed 2022-04-15 | -$584.42K 10-K · filed 2021-04-15 |
| 2019-12-31 | -$1.15M 10-K · filed 2021-04-15 | |
| 2018-12-31 | -$1.02M 10-K · filed 2020-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| LogicMark, Inc. (LGMK) | United States | $0.000B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B |